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Abstract Staphylococcal y-hemolysin consists of Hlgl (or Luk 
F) of 34 kDa and Hlg2 of 32 kDa, which cooperatively lyse 
human erythrocytes. Since y-hemolysin caused swelling of human 
erythrocytes prior to lysis, we studied pore-forming nature of the 
toxin by use of polyethylene glycols as osmotic protectants and 
determined the functional diameter of the pore. To elucidate the 
molecular architecture of the membrane pore formed by y-
hemolysin, we solubilized the pore complex with 2% sodium 
dodecyl sulfate, separated it from erythrocyte membrane proteins 
by sucrose gradient ultracentrifugation, and observed the isolated 
complex under an electron microscope. Our data showed that 
Hlgl and Hlg2 of y-hemolysin assemble into a ring-shaped 195 
kDa complex in a molar ratio of 1 : 1, which may form a 
membrane pore with a functional diameter of 2.1-2.4 nm. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Staphylococcal y-hemolysin has been isolated as a bi-com-
ponent hemolysin from the culture fluids of Staphylococcus 
aureus [1,2,2a]. It consists of Hlgl (or Hy I) of 34 k D a and 
Hlg2 (or Hy II) of 32 kDa, which cooperatively lyse erythro-
cytes from mammalian species [2]. Previous studies by us and 
other groups showed that y-hemolysin shares one component 
with the staphylococcal bi-component leukocytolytic toxin, 
leukocidin (i.e., Hlgl is identical with LukF) [2a-6], and 
that the genes coding for y-hemolysin and leukocidin (i.e., 
hlg2, lukS and lukF = hlgl) are located in a cluster on the 
chromosome of the bacterium [2a,4-8]. 
Our previous studies have demonstrated that the binding of 
Hlgl (or lukF) is a prerequisite for the subsequent binding of 
Hlg2 to the cells [9,10]. We have also analyzed the cell-bound 
state(s) of y-hemolysin by use of SDS-polyacrylamide gel elec-
trophoresis (SDS-PAGE) and Western immunoblot using spe-
cific antisera raised against Hlgl and Hlg2, and showed that y-
hemolysin forms large-molecular-sized complexes of 150-240 
k D a on the cell surface [9,10]. 
In this paper, we show that staphylococcal y-hemolysin as-
sembles into a pore-forming, ring-shaped complex which con-
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Abbreviations: Hlgl, Hlgl (or Hy I) component of staphylococcal y-
hemolysin; Hlg2, Hlg2 (or Hy II) component of y-hemolysin; Tris, 
tris(hydroxymethyl)aminomethane; SDS, sodium dodecyl sulfate; 
SDS-PAGE, SDS-polyacrylamide gel electrophoresis 
sists of Hlgl and Hlg2 in a molar ratio of 1 : 1. This report 
describes the formation of a functional supermolecule by a bi-
component cytolysin, whose components are secreted from 
Staphylococcus aureus as separately existing, water-soluble 
molecules. 
2. Materials and methods 
2.1. Staphylococcus aureus y-hemolysin 
y-Hemolysin was purified from the culture supernatant of Sta-
phylococcus aureus 5R Smith strain as described previously [11]. 
2.2. Hemolytic assay 
Hemolytic assay was performed as described previously [10,12]. 
100% hemolysis was defined as the absorbance value obtained when 
erythrocytes were exposed to 0.5% Triton X-100 at 25 or 37°C for 30 
min. 
2.3. Efflux of potassium ions and hemoglobin from the toxin-treated 
cells 
Human erythrocytes were washed five times by centrifugation at 
600 Xg for 5 min to remove extracellular potassium ions. The washed 
cells (2.5%, v/v) were incubated with Hlgl (2.5 ug/ml) and Hlg2 (2.5 
ug/ml) at 25°C for 5 min, followed by centrifugation at 18 000 X g for 
30 s. A small portion of the supernatant was withdrawn for hemolytic 
assay. The rest of the supernatant was further centrifuged at 
18 000Xg for 20 min to remove erythrocyte membranes, if any. The 
supernatant was dried on a hot plate 70-80°C, decomposed at 550°C 
overnight, and dissolved in a portion of 0.02 M HC1. Atomic absorp-
tion spectro-photometric assay for potassium was performed at the 
wavelength of 766.5 nm with Hitachi Z-8100 Polarized Zeeman 
Atomic Spectrophotometer (Hitachi, Tokyo). 100% release was de-
fined as the concentration of potassium ion or hemoglobin from the 
cell exposed to 0.5% Triton X-100 at 25°C for 30 min. 0% release of 
potassium ion was defined as the concentration from the cells which 
were incubated without toxin at 0°C for 5 min. 
2.4. Estimation of the functional diameter of the pore formed by 
y-hemolysin 
Toxin-induced lysis of human erythrocytes was assayed at 25°C in 
the presence of nonelectrolytes (i.e., polyethylene glycols) with differ-
ent hydrodynamic diameters. The nonelectrolytes were added at a 
concentration equivalent to 40 mosM, and the total osmotic pressure 
of the extracellular space was adjusted to 295 mosM. The value for 
hydrodynamic diameter of the nonelectrolytes were taken from the 
reports of Scherrer and Gerhardt [13] and Sabirov et al. [14], where 
the hydrodynamic diameters were calculated on the viscosity of the 
nonelectrolyte solutions. 
2.5. Complex formation of y-hemolysin on the cell surface 
This was performed essentially as described previously [9,10,12]. 
Human erythrocytes (1%, v/v) were incubated with Hlgl (1-25 ug/ 
ml) and/or Hlg2 (1-25 |ig/ml) at 37°C for 30 min. Toxin-erythrocyte 
complexes were collected by centrifugation at 22000Xg for 20 min 
and suspended in 5 mM sodium phosphate buffer (pH 7.4) to lyse 
intact cells, if any. Toxin-erythrocyte complexes were washed twice by 
centrifugation at 22 000 X g for 20 min, solubilized in a small portion 
of 2% sodium dodecyl sulfate (SDS) at 20°C for 1 min, and subjected 
to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) using a line-
ar gradient gel of 3-14% (w/v) acrylamide. Protein bands in the gel 
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were electroblotted onto a polyvinylidene difluoride sheet for 1 h, and 
immunostained using specific antisera raised against Hlgl and Hlg2. 
2.6. Isolation of toxin complex from erythrocyte membrane by use of 
sucrose density gradient ultracentrifugation 
Erythrocyte-bound toxin was solubilized with 2% SDS at 20°C for 
1 min, and applied to a 10^10% (w/w) linear sucrose density gradient 
in 10 mM Tris HC1 buffer, pH 7.2, containing 0.1 SDS. Centrifuga-
tion was performed using a Beckman SW40Ti rotor at 32 000 rpm for 
19 h at 4°C. Fractions were collected from the bottom of the tubes, 
and analyzed for toxin complexes. The fractions containing toxin 
complexes were combined and concentrated to several folds by use 
of an Amicon Centriflo ultrafiltration membrane (Grave, Danvers, 
MA, USA) at 800 Xg. The concentrated fraction was diluted with 
several volumes of 10 mM Tris HC1 buffer (pH 7.2) containing 
0.1% SDS to reduce the concentration of sucrose, and re-concentrated 
to several folds by ultrafiltration. Toxin complexes were further puri-
fied by the second sucrose density gradient ultracentrifugation as de-
scribed above except the use of a 10-30% (w/w) linear gradient of 
sucrose. 
2.7. Electron microscopy 
Human erythrocytes (1%, v/v) were incubated with Hlgl (1-20 p,g/ 
ml) and Hlg2 (1-20 |ig/ml) at 37°C for 15 min. Lysed erythrocytes 
were placed onto a carbon-coated grid, washed briefly with phosphate 
buffer (pH 7.4), and stained negatively with 1% (w/v) sodium phos-
photungstic acid, pH 7.4. The specimens were examined under a Hi-
tachi electron microscope H-8100 (Hitachi, Tokyo) at an acceleration 
voltage of 100 kV. 
2.8. Miscellaneous 
Protein concentration was assayed as described by Bradford using 
bovine serum albumin as a standard [15]. Osmotic pressure of the 
nonelectrolyte solutions was measured at 25°C using a Micro-Osmom-
eter Model 3MO (Advanced Instruments; Needham Heights, MA, 
USA). Polyethylene glycols were purchased from Wako Chemicals 
(Osaka, Japan). 
3. Results and discussion 
3.1. Pore-forming properties of staphylococcal y-hemolysin 
We monitored the y-hemolysin-induced hemolysis for single 
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Fig. 1. Toxin-induced leakage of potassium ions and hemoglobins 
from h u m a n erythrocytes in the absence or presence of polyethylene 
glycol 6000. H u m a n erythrocytes (2.5%, v/v) were incubated with or 
wi thout Hlg l (2.5 ug/ml) and Hlg2 (2.5 ug/ml) in TBS at 25°C for 
5 min in the absence or presence of polyethylene glycol 6000. The 
cell suspensions were centrifuged at 1 8 0 0 0 X g for 30 s at 4°C, and 
the supernatants obtained were assayed for % leakage of potassium 
ions and hemoglobins as described in Section 2. K + : potassium ion. 
PEG6000: polyethylene glycol 6000. 
100 
o 
E 
a) 
I 
a? 
0.05 
0.05 
0.5 
0.5 
5 
5 
50 Hlgl (ng/ml) 
50 Hlg2 (us/ml) 
Fig. 2. y-Hemolysin-induced lysis of human erythrocytes in the pres-
ence of polyethylene glycols with different hydrodynamic diameters. 
Hemolytic activity of y-hemolysin (Hlgl, 0.05-95 |J.g/ml and Hlg2, 
0.05-95 ug/ml) towards human erythrocytes (0.5%) was assayed at 
25°C in the absence of nonelectrolyte (o) or in the presence of eth-
ylene glycol (•), polyethylene glycol 200 (■), 400 ( A ) , 600 (®), 
1000 (□), 1500 ( A ) or 2000 ( • ) as described in Section 2. 
cells of human erythrocytes under a phase contrast micro-
scope. Intact, disc-shaped erythrocytes became swollen, 
round-shaped cells with clear edge after the incubation with 
Hlgl and Hlg2 of y-hemolysin for 10 min, and the swollen 
cells lysed thereafter. Since swelling of cells is generally caused 
by the permeabilization of cell membranes, we presumed that 
y-hemolysin induced colloid osmotic lysis of human erythro-
cytes through pore formation. To study whether or not y-
hemolysin forms membrane pore, we assayed the leakage of 
potassium ions and hemoglobin from human erythrocytes in 
the presence or absence of polyethylene glycol 6000, a possible 
osmotic protectant. As shown in Fig. 1, toxin-induced hemol-
ysis was suppressed by the addition of polyethylene glycol 
6000 to the extracellular space at a concentration equivalent 
to 40 mosM. In contrast, > 80% of the intracellular potassi-
um ions leaked from the cells within 5 min after addition of y-
hemolysin, irrespective of the presence of polyethylene glycol 
6000. Morphological study of the toxin-treated human eryth-
rocytes indicated that y-hemolysin caused swelling of the er-
ythrocytes in the presence of polyethylene glycol 6000, but it 
did not lyse the cells under the same conditions (data not 
shown). Intact human erythrocytes showed no morphological 
change in the presence of the nonelectrolyte. These data sug-
gested that y-hemolysin formed hydrophilic pores in the cyto-
plasmic membrane of human erythrocytes, eventually induc-
ing colloid osmotic lysis of the cells. They also suggested that 
the functional diameter of the pores was less than the hy-
drated diameter of hemoglobin but larger than that of potas-
sium ion. 
To estimate the functional diameter of the membrane pore 
formed by y-hemolysin, we assayed toxin-induced hemolysis in 
the presence of polyethylene glycols with different hydrody-
namic diameters (Fig. 2). Since intracellular hemoglobin gives 
an osmotic pressure of approximately 33 mosM [16], we 
added the nonelectrolytes to the extracellular space at a con-
centration equivalent to 40 mosM. As shown in Fig. 2, ethyl-
ene glycol and polyethylene glycols 200-600 did not suppress 
the toxin-induced hemolysis. In contrast, the toxin-induced 
hemolysis was inhibited by polyethylene glycol 1000 (with a 
hydrodynamic diameter of 1.8 nm [13,14]) and polyethylene 
glycol 1500 (with a hydrodynamic diameter of 2.1 nm [13,14]) 
N. Sugawara et al.lFEBS Letters 410 (1997) 333-337 335 
B 
Fig. 3. Ring-shaped structures observed on the toxin-treated human 
erythrocytes (A) and ring-shaped toxin complexes isolated from the 
toxin-treated cells (C). Human erythrocytes were lysed by the treat-
ment with y-hemolysin (5 ug/ml of Hlgl and 5 ug/ml of Hlg2) (A) 
or hypotonic 5 mM phosphate buffer, pH 7.4 (B). The complex-con-
taining fraction was obtained from the second sucrose density gra-
dient ultracentrifugation (the same fraction as in Fig. 4B) (C). The 
lysed erythrocytes and the isolated toxin complexes were stained 
negatively with 1% sodium phosphotungstic acid, and subjected to 
electron microscopy. Arrow heads indicate typical ring-shaped struc-
tures. The bar represents 50 nm. 
in accordance with their size. No more hemolysis was detected 
in the presence of polyethylene glycols with an average mo-
lecular weight of >2000 (Fig. 2). Since polyethylene glycol 
2000 has a hydrodynamic diameter of 2.4 nm [13,14], these 
data suggested that y-hemolysin forms a hydrophilic pore with 
a functional diameter of 2.1-2.4 nm in the cell membrane of 
human erythrocytes. 
3.2. Assembly of y-hemolysin into a ring-shaped structure on 
the cell surface 
To elucidate the molecular architecture of the membrane 
pore formed by y-hemolysin, we performed morphological 
and chemical studies on the cell-bound toxin. For morpho-
logical analysis, toxin-treated erythrocytes were stained nega-
tively with 1% sodium phosphotungstic acid and subjected to 
electron microscopy. As shown in Fig. 3A, the image of the 
toxin-treated erythrocytes showed the ring-shaped structures 
on their surface, whose outer and inner diameter were approx-
imately 7 and 3 nm, respectively. In contrast, osmotically 
lysed erythrocytes did not carry such a ring-shaped structure 
on their cell surface (Fig. 3B). Neither Hlgl nor Hlg2 formed 
the ring-shaped structure on the cells in the absence of their 
counterpart (data not shown). These data suggested that y-
hemolysin assembled into the ring-shaped structure with a 
inner diameter of approximately 3 nm on the cell surface, 
forming the hydrophilic pore with a functional diameter of 
2.1-2.4 nm in the cell membrane. 
Our previous studies of the cell-bound y-hemolysin by using 
Western immunoblot analysis suggested that y-hemolysin 
formed large-molecular-sized (150-240 kDa) complexes on 
the cell surface [9,10]. However, the molecular architecture 
of the toxin complexes remained to be elucidated. Based on 
the observation that the toxin complexes were stable in the 
presence 2% SDS at the temperatures below 40°C but disso-
ciated to give monomers of Hlgl and Hlg2 at 100°C [9,10], we 
attempted to isolate the ring-shaped structure formed by y-
hemolysin from erythrocyte membrane: Cell-bound toxin was 
solubilized with 2% SDS at 20°C, and the solubilized toxin 
was fractionated by the two steps of sucrose linear density 
gradient ultracentrifugation. Fractions obtained from the first 
ultracentrifugation using a 10^-0% (w/w) sucrose linear gra-
dient were subjected to SDS-PAGE on a gradient gel of 3 -
14% acrylamide, followed by Western immunoblotting using 
specific antisera raised against Hlgl and Hlg2. As shown in 
Fig. 4A, the solubilized toxin was fractionated into two por-
tions (fraction I and II), which gave the immunostained bands 
corresponding to the toxin complexes of >195 kDa and the 
toxin monomers, respectively. Since the fraction I contained a 
substantial amount of the >195 kDa complexes (Fig. 4A) but 
few membrane protein (data not shown), it was further frac-
tionated by the ultracentrifugation using a 10-30% (w/w) su-
crose linear gradient and analyzed by Western immunoblot 
(data not shown). The peak fraction containing the >195 
kDa complexes was treated with 2% SDS at 20 or 100°C 
for 5 min and subjected to SDS-PAGE, followed by staining 
with Coomassie brilliant blue R-250 (Fig. 4B). The toxin com-
plexes of > 195 kDa were dissociated to monomeric Hlgl and 
Hlg2 in a molar ratio of 1.0:0.97 when heated at 100°C in the 
presence of 2% SDS (Fig. 4B and C). A similar value was 
obtained for the molar ration of Hlgl to Hlg2 when only 
the 195 kDa band was cut out from the gel and analyzed 
by SDS-PAGE (data not shown). Although SDS-PAGE of 
the peak fraction revealed two faint bands of approximately 
100 kDa and 220 kDa (Fig. 4B, lane 1), no increase occurred 
in the intensity of these bands upon the treatment of the same 
fraction with 2% SDS at 100°C (Fig. 4B, lane 2). Thus, it is 
likely that no membrane protein was included in the toxin 
complexes that were formed on the surface of human eryth-
rocytes. Electron microscopy of the same fraction showed the 
presence of the ring-shaped structures, whose dimensions co-
incided with those of the ring-shaped structure observed on 
the toxin-treated cells (Fig. 3C). Substantial portion of the 
ring-shaped structures formed clusters in the fraction (Fig. 
3C), suggesting that the toxin bands of >195 kDa in the 
fraction (Fig. 4B) may correspond to parts of the clusters of 
the ring-shaped toxin complexes. We also observed that nei-
ther Hlgl nor Hlg2 formed the ring-shaped structures as well 
as the large-molecular sized complexes of a 195 kDa in the 
absence of their counterpart (data not shown). 
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Fig. 4. Separation of the solubilized toxin complex(es) by sucrose density gradient ultracentrifugation. (A) Western immunoblot analysis of the 
toxin complexes in the fractions obtained from the 1st sucrose density gradient ultracentrifugation. Cell-bound y-hemolysin was solubilized with 
2% SDS at 20°C, fractionated by a 10-40% (w/w) sucrose linear density gradient ultracentrifugation, and subjected to Western immunoblot as 
described in Section 2. (B) SDS-PAGE of the toxin complex-containing fraction from the 2nd sucrose density gradient ultracentrifugation. The 
fraction I obtained from the first sucrose gradient ultracentrifugation was further fractionated by a subsequent 10-30% (w/w) sucrose linear 
density gradient ultracentrifugation. The peak fraction for the a 195 kDa complexes was treated with 2% SDS at 20 (lane 1) or 100°C (lane 2) 
for 5 min, and subjected to SDS-PAGE. The gel was stained with Coomassie brilliant blue R-250. (C) Densitometry was performed for the 
stained bands of Hlgl and Hlg2 in lane 2 of (B). 
Based on the data described above, we concluded that y-
hemolysin assembles into a ring-shaped complex composed of 
Hlgl and Hlg2 in a molar ratio of 1 : 1, which may form a 
membrane pore with a functional diameter of 2.1-2.4 nm in 
the cell membrane. A single ring-shaped Hlgl-Hlg2 complex 
may be a hexamer structure consisting of three molecules of 
each of Hlgl and Hlg2. 
Acknowledgements: We are very grateful to Mr. Tsuruji Sato for his 
excellent technical assistance in electron microscopy. This work was 
supported in part by the grants from The Ministry of Education, 
Science, Sports and Culture of Japan (08307004 to Y.K.; 08670298 
and 08219203 to T.T.) and from Takeda Science Foundation (to 
Y.K.). 
References 
[1] Smith, M.L. and Price, S.A. (1938) J. Pathol. Bacteriol. 47, 379-
393. 
[2] Guyonnet, F. and Plommet, M. (1970) Ann. Inst. Pasteur 118, 
19-33. 
N. Sugawara et al.lFEBS Letters 410 (1997) 333-337 337 
[2a] Tomita, T. and Kamio, Y. (1997) Biosci. Biotech. Biochem. 61, 
565-572. 
[3] Kamio, Y., Rahman, A., Nariya, N., Ozawa, T. and Izaki, K. 
(1993) FEBS Lett. 321, 15-18. 
[4] Rahman, A., Izaki, K. and Kamio, Y. (1993) Biosci. Biotech. 
Biochem. 57, 1234-1236. 
[5] Supersac, G., Prevost, G. and Piemont, Y. (1993) Infect. Immun. 
61, 580-587. 
[6] Coony, J., Kienle, Z., Foster, T.J. and O'Toole, P.W. (1993) 
Infect. Immun. 61, 768-771. 
[7] Rahman, A., Izaki, K., Kato, I. and Kamio, Y. (1991) Biochem. 
Biophys. Res. Commun. 181, 138-144. 
[8] Rahman, A., Nariya, H., Izaki, K., Kato, I. and Kamio, Y. 
(1992) Biochem. Biophys. Res. Commun. 184, 640-646. 
[9] Ozawa, T., Kaneko, J. and Kamio, Y. (1995) Biosci. Biotech. 
Biochem. 59, 1181-1183. 
[10] Kaneko, J., Tomita, T. and Kamio, Y. (1997) Biosci. Biotech. 
Biochem. 61, 846-851. 
[11] Nariya, H., Asami, I., Ozawa, T., Beppu, Y., Izaki, K. and Ka-
mio, Y. (1993) Biosci. Biotech. Biochem. 57, 2198-2199. 
[12] Tomita, T., Watanabe, M. and Yasuda, T. (1992) J. Biol. Chem. 
267, 13391-13397. 
[13] Scherrer, R. and Gerhardt, P. (1971) J. Bacteriol. 107, 718-735. 
[14] Sabirov, R.Z., Krasilnikov, O.V., Ternovsky, V.I. and Merziliak, 
P.G. (1993) Gen. Physiol. Biophys. 12, 95-111. 
[15] Bradford, M.M. (1976) Anal. Biochem. 72, 248-254. 
[16] Freedman, J.C. and Hoffman, J.F. (1979) J. Gen. Physiol. 74, 
157-185. 
